✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
591daili 济南圣和化工
首页 › 产品目录 › 利西拉来

利西拉来

CAS 320367-13-3C215H347N61O65SMW 4858

利西拉来,CAS 登记号 320367-13-3,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号320367-13-3
分子式C215H347N61O65S
分子量4858
LogP-30.8
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 利西拉来 的 CAS 号?

本页已列出 利西拉来 的 CAS 号:320367-13-3,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

利西拉来 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Lixisenatide · CAS 320367-13-3 · C215H347N61O65S. UNII 74O62BB01U.

Identification

CAS Registry Number320367-13-3
PubChem CID90472060
Molecular formulaC215H347N61O65S
UNII (FDA)74O62BB01U

Computed Descriptors

Molecular Weight4858
XLogP3-30.8
Hydrogen Bond Donor Count70
Hydrogen Bond Acceptor Count77
Rotatable Bond Count170
Exact Mass4857.5510314
Monoisotopic Mass4855.5443218
Topological Polar Surface Area2090
Heavy Atom Count342
Formal Charge0

GHS Hazard Classification

Reported hazard statementsH318 (100%), H361 (100%)

H318 (100%): Causes serious eye damage [Danger Serious eye damage/eye irritation]

H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

Documented Uses

  • Lixisenatide is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type II diabetes mellitus. It is also available in combination with [insulin glargine] for the same indication.
  • Lixisenatide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. Therapy with lixisenatide has not been associated with serum enzyme elevations or with episodes of clinically apparent liver injury.
  • Breast Feeding; Lactation; Milk, Human; Hypoglycemic Agents; Incretins; Glucagon-Like Peptide-1 Agonists; GLP-1 Agonists
  • Take at the same time every day.
  • Take before a meal. Take lixisenatide within one hour before the first meal of the day.
  • Established Pharmacologic Class [EPC] - GLP-1 Receptor Agonist

Synonyms

Lixisenatide; Adlyxin; Lyxumia; ZP10A peptide; 320367-13-3; ZP 10; AVE0010; AQVE-10010; AVE 0010; lixisenatida; lixisenatidum; AVE 010; AVE-010; ZP-10; AVE-0010; Des-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-L-lysyl-L-lysinamide

Frequently Asked Questions

What are the CAS number and molecular formula of Lixisenatide?

CAS 320367-13-3; molecular formula C215H347N61O65S; molecular weight — g/mol.

What other names is Lixisenatide known by?

Lixisenatide, Adlyxin, Lyxumia, ZP10A peptide, 320367-13-3, ZP 10.

Is Lixisenatide classified as hazardous?

Hazard statements reported: H318, H361.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 利西拉来 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1